BSE filing, NSE: FLORATX. Summary written from the filing by ALFA Finder's alert engine.
Anirit Ventures Ltd: key numbers
- Share price
- ₹32.30
- Market cap
- ₹58.14 Cr
- Revenue (annual)
- ₹0.00 Cr
- Net profit (annual)
- ₹-4.76 Cr
- P/E (TTM)
- -12.6×Sector 49.8×
- Promoter holding
- 55.53%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Anirit Ventures Ltd
All →Anirit Ventures Other Announcement
The company filed its quarterly shareholding pattern for the period ended September 30, 2026, as per SEBI regulations.
Anirit Ventures Q1 FY27 Results: Net Loss of ₹1 Cr, Loss Narrows
Anirit Ventures Ltd reported a net loss of ₹1 Cr for Q1 FY27.
- Key figure
- Net loss ₹1 Cr
Anirit Ventures Annual General Meeting
Anirit Ventures Ltd held its AGM, where shareholders approved financial statements, director appointment, and a related party borrowing transaction of ₹10 Crore.
- Value
- ₹10.00 Cr
Anirit Ventures Annual General Meeting
Anirit Ventures held its 33rd Annual General Meeting on July 30, 2026, considering financial statement adoption and related party borrowing limits.
Anirit Ventures Other Announcement
Anirit Ventures Ltd filed its quarterly shareholding pattern for the period ended June 30, 2026, as per regulatory requirements.
Anirit Ventures Annual Report
Anirit Ventures Ltd filed its Annual Report for FY 2025-26. The report details its strategic pivot to agri-tech and sustainability under new ownership.
Other board meeting date announcements
All →Ultracab (India) Board Meeting Date
Ultracab (India) Ltd intimated that its Board meeting is scheduled for 04-Nov-2026 to consider unaudited standalone financial results. No results or financial figures are disclosed in this advance notice.
Texmaco Infrastructure & Holdings Board Meeting Date
Texmaco has scheduled a Board meeting on November 5, 2026, to approve Q2 and H2 FY27 financial results. Trading window stays closed for insiders pending results declaration.
Astonea Labs Board Meeting Date
Astonea Labs intimated that its Board is scheduled on 14 Nov 2026 to consider unaudited half-year results. The trading window remains closed until 48 hours post-announcement.
AstraZeneca Pharma India Board Meeting Date
AstraZeneca Pharma India scheduled its board meeting for 5 Nov 2026 to approve Q2/H1 FY27 results. The trading window remains closed until 7 Nov 2026.
Mafatlal Industries Board Meeting Date
Mafatlal Industries updated that its 4 November 2026 board meeting will consider an interim dividend for FY27. Record date, if approved, is 13 November 2026.
Inventurus Knowledge Solutions Board Meeting Date
Inventurus Knowledge Solutions will hold a board meeting on 05 November 2026 to consider September 2026 results. This advance notice reports no approved results yet.